# Wellster Healthtech Group

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/wellster-healthtech-group

- Industry: Software
- Headquarters: Munich, Germany
- Website: www.wellsterhealth.com
- Total disclosed funding: $62M
- Latest round: Series B (Jan 18, 2022)
- Investors on record: 6

## About

Based in Munich, Germany, and founded in 2018, Wellster Healthtech Group GmbH is a provider of telemedicine platform solutions. It creates effortless access to effective healthcare for everyone to enjoy the best health outcome they desire. Dr. Manuel Nothelfer and Nico Hribernik are the founders of Wellster Healthtech Group. The company was initially founded as Direct Health Service. 

Wellster Healthtech Group integrates telemedicine, drug-based and digital therapies into vertical ‘Direct-to-Consumer’ solutions, each of which is tailored to a specific health topic. The healthtech startup also assists pharmacists in accessing online channels, overall providing local pharmacies with additional revenue opportunities and enabling them to create contemporary customer loyalty. Wellster Healthtech Group has a brand ‘Spring’ in Germany, including portals gospring.de (intimate health) and myspring.com (hair loss), in addition to portals for mental health and medical self-tests.

## Funding rounds

- Series B, Jan 18, 2022, $20M — HV Capital, SevenVentures, German Media Pool, Dermapharm AG
- Series B, May 26, 2021, $43M — HV Capital, SevenVentures, German Media Pool, Dermapharm AG, HGDF Familienholding, F4
- Seed, Mar 31, 2020 — HV Capital, HGDF Familienholding

## Investors

- HV Capital (https://capitalatlas.ai/funds/hv-capital) — Seed, Series B
- HGDF Familienholding — Seed, Series B
- SevenVentures (https://capitalatlas.ai/funds/sevenventures) — Series B
- German Media Pool (https://capitalatlas.ai/funds/german-media-pool) — Series B
- Dermapharm AG — Series B
- F4 (https://capitalatlas.ai/funds/f4) — Series B